APA (7th ed.) Citation

JI, C., L, A., AL, P., E, M., L, J., DA, M., . . . H, K. (2023). Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer, 11(3), . https://doi.org/10.1136/jitc-2022-006570

Chicago Style (17th ed.) Citation

JI, Caulfield, et al. "Germline Genetic Variants Are Associated with Development of Insulin-dependent Diabetes in Cancer Patients Treated with Immune Checkpoint Inhibitors." Journal for Immunotherapy of Cancer 11, no. 3 (2023). https://doi.org/10.1136/jitc-2022-006570.

MLA (9th ed.) Citation

JI, Caulfield, et al. "Germline Genetic Variants Are Associated with Development of Insulin-dependent Diabetes in Cancer Patients Treated with Immune Checkpoint Inhibitors." Journal for Immunotherapy of Cancer, vol. 11, no. 3, 2023, https://doi.org/10.1136/jitc-2022-006570.